Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.455 USD | -1.52% | -1.72% | -12.09% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.09% | 411M | |
+0.58% | 43.84B | |
+5.42% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.27% | 25.53B | |
-24.47% | 18.18B | |
-3.48% | 12.29B | |
+26.27% | 12.29B | |
+6.64% | 11.15B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Transcript : Voyager Therapeutics, Inc., Q3 2022 Earnings Call, Nov 08, 2022